Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-01 | VERACYTE, INC. | EASTHAM KARIN
(Director) |
S | Common Stock | D | 10000 | $21.65 - $21.65 | $216,528 |
2024-04-01 | VERACYTE, INC. | EASTHAM KARIN
(Director) |
M | Common Stock | A | 10000 | $13.19 - $13.19 | $131,900 |
2024-03-06 | VERACYTE, INC. | Stapley Marc
(Chief Executive Officer) |
A | Common Stock | A | 114724 | $0.00 - $0.00 | $0 |
2024-03-06 | VERACYTE, INC. | Leite John
(Chief Commercial Officer-CLIA) |
A | Common Stock | A | 49880 | $0.00 - $0.00 | $0 |
2024-03-06 | VERACYTE, INC. | McGuire Annie
(SVP, General Counsel) |
A | Common Stock | A | 49880 | $0.00 - $0.00 | $0 |
2024-03-06 | VERACYTE, INC. | Wygant Jonathan
(VP, Chief Accounting Officer) |
A | Common Stock | A | 23942 | $0.00 - $0.00 | $0 |
2024-03-06 | VERACYTE, INC. | Chambers Rebecca
(Chief Financial Officer) |
A | Common Stock | A | 59856 | $0.00 - $0.00 | $0 |
2024-03-06 | VERACYTE, INC. | Febbo Phillip G.
(Chief Scientific & Med Officer) |
A | Common Stock | A | 39904 | $0.00 - $0.00 | $0 |
2024-03-02 | VERACYTE, INC. | Wygant Jonathan
(VP, Chief Accounting Officer) |
F | Common Stock | D | 2337 | $24.00 - $24.00 | $56,088 |
2024-03-01 | VERACYTE, INC. | JONES EVAN/ FA
(Director) |
S | Common Stock | D | 10000 | $24.36 - $24.36 | $243,599 |
2024-03-01 | VERACYTE, INC. | JONES EVAN/ FA
(Director) |
M | Common Stock | A | 10000 | $13.19 - $13.19 | $131,900 |
2024-03-02 | VERACYTE, INC. | Chambers Rebecca
(Chief Financial Officer) |
F | Common Stock | D | 6112 | $24.00 - $24.00 | $146,688 |
2024-03-02 | VERACYTE, INC. | Leite John
(Chief Commercial Officer-CLIA) |
F | Common Stock | D | 3008 | $24.00 - $24.00 | $72,192 |
2024-03-02 | VERACYTE, INC. | Stapley Marc
(Chief Executive Officer) |
F | Common Stock | D | 13286 | $24.00 - $24.00 | $318,864 |
2023-12-02 | VERACYTE, INC. | Wygant Jonathan
(VP, Chief Accounting Officer) |
F | Common Stock | D | 507 | $26.54 - $26.54 | $13,455 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |